CCO Treatment Updates

New Strategies for Regaining Control of HIV Replication in Treatment-Experienced Patients

On-Demand Video Conference

Webcast: New Strategies for Regaining Control of HIV Replication in Treatment-Experienced Patients

CME Program Director:
Joseph J. Eron, Jr., MD

Faculty:

Joseph J. Eron, Jr., MD headshotJoel E. Gallant, MD, MPH headshotDaniel R. Kuritzkes, MD headshot
  • Joseph J. Eron, Jr., MD
  • Joel E. Gallant, MD, MPH
  • Daniel R. Kuritzkes, MD
William A. OBrien, MD, MS headshot
  • William A. O'Brien, MD, MS

CME CREDIT INFORMATION

Release Date: 12/12/05

Expiration Date: 12/11/06


Physicians: maximum of 1 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status



Topics include :

  • Current challenges and goals of therapy in multiclass-experienced patients
  • Benefits and risks of incomplete virologic suppression
  • New data from recent scientific meetings on approved and investigational agents, focusing on
    • New protease inhibitors (tipranavir and TMC114)
    • Enfuvirtide and chemokine receptor antagonists


          • Learning Objectives

          Upon completion of this activity, participants should be able to:

          • Review recent data on the use of protease inhibitors and entry inhibitors in multiclass-experienced patients.

          • Discuss the goals of therapy in multiclass-experienced patients, and the consequences of incomplete virologic suppression.

          • Discuss clinical strategies designed to maximize the likelihood of achieving virologic suppression in multiclass-experienced patients.

CCO Slideset – New Strategies for Regaining Control of HIV Replication in Treatment-Experienced Patients


Format: Microsoft PowerPoint (.ppt) | File size: 1,877 KB

Educational Module

Current Data and Treatment Strategies for Controlling HIV Replication in Multiclass-Experienced Patients

CME Program Director:
Joseph J. Eron, Jr., MD

Faculty:

William A. OBrien, MD, MS headshotVictor Mulanovich, MD headshot
  • William A. O'Brien, MD, MS
  • Victor Mulanovich, MD

CME CREDIT INFORMATION

Release Date: 03/02/06

Expiration Date: 03/01/07


Physicians: maximum of 1.75 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status


William A. O’Brien, MD, MS, reviews recent data and management strategies surrounding new treatment options for suppressing viral load in patients with multiclass experience.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss the goals of therapy in multiclass-experienced patients and strategies for optimal use of new agents to regain virologic control
  • Review recent clinical trial data on the use of approved and investigational antiretrovirals in multiclass-experienced patients
  • Discuss clinical strategies for maintaining a patient’s immunologic and clinical status while awaiting new, active agents to construct a suppressive regimen
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grants provided by:

Educational grants support only the CME-certified components of this program.